Sign In
Buy AMGN
$338.22
+9.96 (+3.03%)
At Close: Jun 03, 2026
Markets Close Turbulent Week On A Down Note
08:22pm, Friday, 06'th May 2022 Benzinga
The S&P 500 traded lower in a roller coaster week on Wall Street as investors digested another Federal Reserve interest rate hike and a mixed batch of earnings reports.
On Wednesday, the Federal Reser
Radius (RDUS) Q1 Loss Wider Than Expected, Revenues Decline
04:43pm, Friday, 06'th May 2022 Zacks Investment Research
Radius (RDUS) posts a y/y wider Q1 loss and misses revenue estimates.
7 Defensive Dividend Healthcare Stocks to Buy Now
07:33am, Friday, 06'th May 2022
As market conditions remain rocky, adding high-quality healthcare stocks to your portfolio may be a great way to play defense. The post 7 Defensive Dividend Healthcare Stocks to Buy Now appeared first
Ligand (LGND) Q1 Earnings Beat, OmniAb Spin-Off on Track
03:22pm, Thursday, 05'th May 2022 Zacks Investment Research
Ligand (LGND) reports encouraging first-quarter 2022 numbers by beating estimates on both counts. However, Captisol sales get hurt by lower demand for COVID-19 therapies.
Should Investors Be Worried About Amgen's Q1 Results?
12:20pm, Thursday, 05'th May 2022 The Motley Fool
Much of the company's growth isn't coming from its top-selling drugs.
Should Investors Be Worried About Amgen's Q1 Results?
08:20am, Thursday, 05'th May 2022
Much of the company's growth isn't coming from its top-selling drugs.
Amgen: Another Chance To Average Down
07:00am, Thursday, 05'th May 2022
Amgen's recent results were encouraging, with strong underlying volume growth in key franchises. It has a number of growth prospects in its pipeline, including mid- to late-stage drugs in inflammation
Biotech Stock Roundup: BIIB & GILD's Earnings Update, VRTX Down on Regulatory News
05:39pm, Wednesday, 04'th May 2022 Zacks Investment Research
Earnings and regulatory updates from Bristol Myers (BMY), among others, and Vertex (VRTX) are a few key highlights from the biotech sector during the past week.
Should You Invest in the iShares Biotechnology ETF (IBB)?
10:20am, Wednesday, 04'th May 2022 Zacks Investment Research
Sector ETF report for IBB
Pfizer (PFE) Q1 Earnings & Sales Miss Estimates, Stock Down
02:42pm, Tuesday, 03'rd May 2022 Zacks Investment Research
Pfizer (PFE) misses estimates for Q1 earnings and sales. It did not raise its sales guidance for 2022. Stock declines.
Should Schwab U.S. Dividend Equity ETF (SCHD) Be on Your Investing Radar?
10:20am, Tuesday, 03'rd May 2022 Zacks Investment Research
Style Box ETF report for SCHD
1 Green Flag and 1 Red Flag for Amgen
10:01am, Tuesday, 03'rd May 2022 The Motley Fool
The net net is more black and white for long-term investors.
Why the 5 Highest-Yielding Nasdaq Stocks May Be the Best and Safest Value Buys Now
07:16am, Tuesday, 03'rd May 2022
The Nasdaq has been absolutely obliterated this year, down a stunning 21.2%, which puts the tech-heavy index firmly in bear market territory.
1 Green Flag and 1 Red Flag for Amgen
06:01am, Tuesday, 03'rd May 2022
The net net is more black and white for long-term investors.
Novartis Is Looking for Deals. Are These 3 Biotechs on Its List?
02:45pm, Monday, 02'nd May 2022 The Motley Fool
CEO Vas Narasimhan is seeking acquisitions under $2 billion.
